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Abstract

EFFECTS OF METAL PROTOPORPHYRINS ON BURN WOUND CONVERSION
By Katie Lynne Braun, M.S.
A thesis submitted in partial fulfillment of the requirements for the degree of Master of
Science at Virginia Commonwealth University.
Virginia Commonwealth University, 2008
Major Director: Dorne R. Yager, Ph. D.
Associate Professor & Director of Research, Department of Surgery

A murine model was utilized to test the influence of heavy metal
protoporphyrins on burn conversion, heme oxygenase – 1 (HO-1) expression, and
inflammation. Heavy metal protoporphyrins, such as cobalt protoporphyrin (Co PP) and
tin protoporphyrin (Sn PP), were used to influence the heme oxygenase activity. The
effects of these heavy metal protoporphyrins on burn wound conversion were examined
using a burn comb model in rats.
In addition to assessing the extent of conversion, HO-1 expression and
parameters of inflammation were also examined in the area of injury (interspace region)
subject to conversion. These studies demonstrate proof in principal that pharmacologic
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agents known to modify HO activity can also modulate burn wound conversion.
Improved outcome correlated with HO-1 expression/activity and reduced inflammation.
This suggests that one of the mechanisms utilized by HO-1 to improve burn wound
outcome involves modulation of one or more components of the inflammatory response.
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Introduction

General Purpose

In the United States, approximately two million people each year are subject to
burn injury. Of these, 80,000 require hospitalization, and 6,500 die as a direct or
indirect result of their burn injuries. (Singh, Devgan et al., 2007) Burns and their
recorded treatment date back to the 15th century B.C. In the Ebers papyrus, burn wounds
were treated with “cattle dung and black mud” (Weeks & Xu, 2004). It was not until the
twentieth century that significant progress in the treatment of burn wounds occurred.
With the First World War, autologous surgical skin grafts came into use and beginning
in the 1960s fluid resuscitation techniques greatly reduced mortality resulting from
shock. (Weeks & Xu, 2004)
One of the significant problems that are still encountered with burn wounds is
conversion. For reasons that are not entirely appreciated, burn wound severity is not
always static and can progressively worsen following the initial injury. This is
clinically relevant because it not only confounds diagnosis but, burns that progress from
partial-thickness to full-thickness injury are at a much greater risk for hypertrophic
scarring and contracture. Full-thickness burn wounds also put the individual at
increased risk for sepsis and require surgical interventions. Although the mechanisms
behind burn wound conversion are incompletely understood, there is a consensus that
inflammation plays a major role. (Singh, Devgan et al., 2007)
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The stress protein, heme oxygenase-1 (HO-1) generates products with antiinflammatory functions. The expression and activity of HO-1 can be pharmacologically
modulated by heavy metal protoporphyrins. Therefore, the goals of this study were:
1. test whether heavy metal protoporphyrins influence burn conversion
2. test whether protoporphyrins influence HO – 1 expression
3. test whether heavy metal protoporphyrins influence inflammation, using
markers such as myeloperoxidase (MPO) and matrix metalloproteinase
(MMP) expression

Hypothesis

Experimental analysis will demonstrate that heavy metal protoporphyrins, tin
protoporphyrin (Sn PP) and cobalt protoporphyrin (Co PP) will have an effect on the
conversion of the burn injury. By testing the key elements in the Co PP and Sn PP
treated inflamed tissue, will show that HO-1 expression is increased. Heavy metal
protoporphyrins should modulate HO-1 expression. Inflammation and necrosis should
correlate with an environment in which HO-1 is inhibited, and should inversely
correlate with a pharmacologic regimen that increased HO-1 activity. There is a
correlation between Co PP and Sn PP treatments that modulate HO-1
expression/activity with inflammation and necrosis. Co PP and Sn PP should be
observed to have a significant influence on the inflammation of the burned tissue and
MMP expression.
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Background

When skin is heated, it is subject to damage as a result of the transfer of thermal
energy. Temperature and duration of exposure are the two most important determinants
of the degree of injury. Physics dictates that thermal damage is dependent upon the
quantity of heat that is transferred and the extent to which it is dissipated. The last two
decades have seen significant advances in burn care. The number of deaths annually in
the United States is now less than a third of that seen in 1970. Moreover, the size of
burn associated with a 50 percent survival rate has increased from 30% of the total body
surface area to well over 80% in otherwise healthy adults. (Warden & Heimbach, 1999)
The skin is composed of layers, all of which can be affected by a burn depending on
the severity. The three main layers are the epidermis, dermis, and hypodermis. The
epidermis consists of different types of cells: keratinocytes, melanocytes, Merkels cells,
and Langerhans cells. Blood vessels can not be found in the epidermis, but oxygen and
nutrients reach the tissue by way of diffusion from the dermis. The main function of the
epidermis is to act as a protective barrier. The epidermis is divided into five separate
layers. Starting from the top, there is the stratum corneum, stratum lucidum, stratum
granulosum, stratum spinosum, and the stratum basale, which borders the dermis. The
stratum corneum is composed of dead cells or cells that are close to death. This sublayer of the epidermis acts as a protective surface due to the strength of the keratin
protein in the dying cells. Although this layer has many dying cells, hydration is still
possible. The stratum lucidum is only apparent in thick skin which helps to decrease
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friction. The stratum granulosum contains keratinocytes which produce keratin proteins
and lipids responsible for hydration of the epidermis. The stratum spinosum again
contains keratinocytes which begin the production of keratin. Langerhans cells are also
found in the stratum spinosum and are very important to the epidermis. These cells
relay signals to the immune system and help to protect to body from foreign invaders or
any other trauma to the skin. The last layer of the epidermis is the stratum basale and its
main function is to form new cells that are forced upward as the stratum corneum
sloughs off dying cells. The stratum basale contains melanocytes and Merkels cells.
Melanocytes produce melanin pigment to help protect the skin from sun damage.
Merkels cells do not have a determined function, but could potentially be related to the
touch sense. (Brannon, 2007; Gary, 2008; Kenet & Lawyer, 1994)
The dermis is made up of two layers: papillary and reticular layer. The upper level is
the papillary dermis and the lower level is the reticular dermis. The whole dermis is
formed from connective tissue. Specifically, the papillary layer is composed of thin
collagen fibers and the reticular layer is made up of thick collagen fibers, which provide
support. There are many more components involved in the dermis. Elastin runs
throughout this layer, which provides elasticity to the skin. The dermis also contains
hair follicles and erector pili muscles, sweat glands, blood vessels, lymph vessels, and
nerves. Meissner’s and Pacini corpuscles in the dermis sense touch and pressure.
Histiocytes are found in the dermis as well, and serve as important factors involved in
the healing process and regeneration of the epidermis. Monocytes derived from the
bone marrow become histiocytes when arriving in the dermis in response to trauma.
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Overall, the dermis provides elasticity, support, and strength to the skin and begins
the process of repair. (Gomez & Cancio, 2007) Therefore, the deeper a burn progresses
into the skin, the more severe a burn (Singh, Devgan et al., 2007).
The innermost layer of the skin is the hypodermis. The hypodermis contains much
of the fat stored in the body, but also consists of connective tissue, large blood vessels,
hair follicle roots, and nerve endings. The adipose cells in this layer act as a shock
absorber and provide insulation for the body. (Hettiaratchy & Dziewulski 2004;
Benson, Dickson et al., 2006)
The extent of burn wound damage in the layers of the skin is commonly classified in
terms of degrees. First degree burns (or superficial burns) are the most minor and do
the least amount of damage. These burns will make the skin turn pink or red and only
affects the epidermis. An example would be a typical sun burn. Second degree burns (or
partial-thickness burns) extend deeper into the skin and involve all or part of the dermis.
Second degree burns can be sub-classified as superficial partial-thickness burns
(involving the papillary dermis) or deep partial-thickness burns (involving the papillary
and reticular dermis). Second degree burns result in blistering of the skin, can be painful
depending on the quantity and depth of nerves affected, and result in damage to the
epidermis and dermis. Third degree burns involve the epidermis, dermis, and extend
into the subcutaneous tissues. Severe burns can involve muscle and bone. (Barton,
Kokoska et al., 2006; Gomez & Cancio, 2007) See Figure 1.
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Figure 1: Degree Levels of Burns
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In addition, individual burn wounds are also defined in terms of evolving injury.
Burn wound conversion is a process in which superficial burns develop into deeper burn
wounds. Jackson was the first to determine that a burn can be observed as three separate
zones: the zone of coagulation, the zone of stasis, and the zone of hyperemia. See
Figure 2. The zone of coagulation refers to the area of injured tissue which has received
irreversible damage. The tissue has been destroyed and the cells die extremely quickly.
This area is void of any blood flow and damage is irreversible. Deep and peripheral to
the zone of coagulation is the zone of stasis. Due to direct thermal effects, the
microvasculatures in this region dilate and its endothelial lining '
leaks'plasma and
intravascular proteins. With time, the circulation in this region ceases as the capillaries
become packed with red blood cells and microthrombi, aggravating the inflammatory
response. With appropriate treatment, the cellular damage in this region is potentially
reversible. The outermost zone is the zone of hyperemia. Damage in this area is severe,
but not permanent. The blood flow increases daily and healing should be apparent after
about a week. (Gomez & Cancio, 2007; Singh, Devgan et al., 2007)
“The depth of burn wounds is not entirely static, however, and multiple factors, each
acting via a variety of pathophysiologic mechanisms, can promote the deepening of
a burn wound. In a subacute time frame of 3–5 days, burns originally assessed to be
superficial partial thickness have been observed to progress into deep partial-thickness
or full-thickness burns. This process of progressive damage to initially unburned tissue
surrounding a burn wound is referred to as burn wound progression, which remains
clinically important but poorly understood” (Singh, Devgan et al., 2007).
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Figure 2: Zones of Stasis in Burn Wound Conversion
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A number of systemic and local factors and cellular mechanisms can be involved in
burn wound conversion. Local and systemic factors include infection, edema, altered
perfusion caused by circumferential eschar, general health (e.g., age), shock, inadequate
fluid resuscitation, cytokine alterations, and pathologies such as atherosclerosis,
peripheral vessel disease, and diabetes. Edema, decreased fluid resuscitation, and
altered perfusion can all cause cell death because of a drop in intravascular and
interstitial fluid volumes. The alterations in cytokine levels increase the chances of
infection. Diabetes can occur due to decreased metabolic function. General health is
very important as well because with a compromised immune system due to age or
lifestyle, the ability for the body to heal is reduced. Models that have been used to study
factors that affect burn wound conversion have already showed that fluid resuscitation
can turn a partial thickness burn into a full thickness burn. (Singh, Devgan et al., 2007)
Molecular mechanisms that have been suggested to contribute to burn wound
conversion are diverse but most are directly or indirectly related to inflammation.
Prostaglandins are formed through the action of cyclooxygenase. Certain prostaglandins
are inhibitors of platelet aggregation and serve to vasodilate, whereas others act as
potent vasoconstrictors and promote aggregation of platelets. Alterations in prostanoid
levels can lead to vasoconstriction and thus a reduction in perfusion. (Robson, 1979)
Conversely, increased levels of nitric oxide and pro-inflammatory cytokines can cause
vasodilation resulting in edema and tissue congestion (Rawlingson, 2003).
In 1968, McCord and Fridovich proposed that the enzyme xanthine oxidase was the
major source of free radicals that contributed to reperfusion injury. Altered peripheral
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perfusion decreases the oxygen available to peripheral tissues that is required for
adenosine triphosphate (ATP) production. As ATP depletion occurs, the level of
adenosine monophosphate (AMP) rises and, in turn, is catabolized to hypoxanthine.
The return of molecular oxygen to previously ischemic tissues results in hypoxanthine
serving as a substrate for xanthine oxidase. In a series of complicated reactions,
hypoxanthine is converted to xanthine and ultimately to uric acid, and this process
produces hydrogen peroxide and superoxide, deleterious oxygen-derived free radicals.
(McCord & Fridovich, 1968)
Another major source of reactive oxygen species (ROS) in burn trauma comes from
activated neutrophils. Activated neutrophils produce a burst of free radicals (Basadre et
al., 1988; Horton et al., 1996; Horton & Garcia, 1995; Mileski et al., 1991). This
neutrophil-related function serves a significant protective mechanism by scavenging
invading bacteria; however, with injury such as burn trauma, a burst of neutrophilproduced free radicals in addition to xanthine oxidase activity, may result in
overwhelming tissue damage. Moreover, while burn trauma increases ROS production,
this type of traumatic injury also impairs antioxidant defense mechanisms, rendering the
burn subject more susceptible to oxygen free radical mediated injury. For example,
numerous studies have shown that burn trauma alters non-enzymatic defense
mechanisms including decreases in alpha tocopherol, and ascorbic acid. These
endogenous antioxidant mechanisms protect membranes against lipid peroxidation,
scavenge oxygen derived free radicals, and dissipate free radical energy. In addition,
burn trauma alters enzymatic defense mechanisms including altered superoxide
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dismutase levels, reduced catalase and reduced glutathione levels (Cynober et al., 1985;
Demling et al., 1995; Demling and LaLonde, 1990a; Demling and LaLonde, 1990b;
LaLonde et al., 1992; LaLonde et al., 1997a; LaLonde et al., 1997b; Nguyen et al.,
1993; Rai & Courtemanche, 1975; Sasaki et al., 1990).
Recent attention has focused on the hypothesis that the accumulation of reactive
biochemical species such as oxygen derived free radicals and non-radicals such as
hydrogen peroxide and nitric oxide promote and exacerbate the inflammatory response
(Cain et al., 1999; Giroir et a., 1994). Inflammation is a standard immediate response to
inury, including burns. Acute inflammation is a natural defense to skin trauma. Nonspecific inflammation activates cascades such a complement, prostaglandins, and then
the migration of neutrophils. Burn wounds have been observed to produce the nonspecific inflammatory response, although it has not been proven. Mediators of the
inflammatory response act locally and systemically. Cytokines produced in response to
inflammation initiate the leukocyte response. Overproduction of cytokines can lead to a
“domino effect” and the inflammatory response can become widespread leading to
systemic inflammatory response syndrome, acute respiratory distress syndrome, or
multiple organ dysfunction syndrome. Although there are many cell types involved in
the inflammatory response, research on animal models has shown that neutrophils and
macrophages tend to predominate the injured tissue. (Tyler, Watts et al., 2000;
Dokumcu, Ergun et al., 2008)
In addition to their ability to generate ROS, neutrophils possess several types of
granules in which are packaged large amounts of degradative enzymes such as serine
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proteinases (e.g., elastase and cathepsin G) and matrix metalloproteinases (e.g., MMP-8
and MMP-9). Although these enzymes and the associated respiratory burst are
designed to aid in debridement of devitalized tissues and destruction of microbes there
is a growing appreciation that an over exuberant response by neutrophils can lead to
additional damage of tissues. (Yager & Nwomeh, 1999)

Heme Oxygenase – 1

As outlined in the preceding section, there is evidence that a number of local and
molecular factors associated with inflammation are involved in burn wound conversion.
Therefore, targeting the inflammatory response could provide a means for modulating
conversion. Heme oxygenases are very important in the response to injury by
amplifying inflammation (Burger, Xiang et al., 2008). Being able to control heme
oxygenase (HO) would be extremely beneficial to decreasing the effects of burn wound
conversion.
HO is the first and rate-controlling enzyme of the degradation of heme into iron,
carbon monoxide, and biliverdin, the latter being subsequently converted into bilirubin.
See Figure 3. Several positive biological effects exerted by this enzyme have gained
attention. Heme is a potent oxidant, removal of free heme from the area of a burn
injury is likely to be beneficial. Perhaps just as important, carbon monoxide and
bilirubin have been attributed to possess anti-inflammatory, antiapoptotic, angiogenic,
and cytoprotective functions. (Farombi & Surh, 2006) Experimentation conducted by
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Burger studied the effects that HO-1 had on erythropoietin (EPO), which is a hormone
that can protect the heart from ischemia and reperfusion. EPO was shown to induce
expression of HO-1. Apoptosis was decreased by an increase in expression of HO-1.
Burger showed that the “selective inhibition of HO-1 using chromatin mesoporphyrin
(CrMP) significantly diminished the ability of erythropoietin to inhibit apoptosis.” HO1 appeared to introduce a protective role in regards to arthrosclerosis and endotoxemia.
(Burger, Xiang et al., 2008) Thus, the physiological induction of HO-1 may be an
adaptive and beneficial response to several possibly noxious stimuli, including heme
itself, suggesting a potentially autoprotective and autodefensive role in burn wound
pathology.
There are two genetic isoforms: HO-1 and HO-2. HO-1 expression is inducible in
virtually every cell type. In contrast, HO-2 is expressed constitutively in a limited
number of tissues amino acids. (Farombi & Surh, 2006) HO – 1 binds to heme in a 1:1
ratio. HO-1 in humans portrays a flexible bihelical structure which encompasses the
heme pocket. Expression of HO-1 is apparent in large concentrations in the spleen,
liver, and bone marrow. Within cells HO is abundant in the endoplasmic reticulum.
Studies have provided some evidence of HO expression in the plasma membrane and
the nucleus. (Ryter, Alam et. Al, 2006) Under normal physiological conditions most
other tissues express only very low levels of HO-1.
HO-1 synthesis is greatly amplified in response to biological stress of the body and
tissues and serves as a protective mechanism in response to many different stimuli. For
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example, heat shock, oxidative stress, UV radiation, and hydrogen peroxide are all
found to induce the synthesis of HO-1. Although outside stresses can influence the
levels of HO-1 produced in the body, injury or infection caused by systemic stress can
also bring about the cytoprotectant role of HO-1. HO-1 is strongly activated by a
number of proinflammatory agents. Devey studied ischemia reperfusion injury in the
liver. HO-1 was observed to have anti-inflammatory actions and protect cells from
oxidative injury. When HO-1 was deleted in mice, the animals were susceptible to
hepatic ischemia reperfusion (Devey, Ferenbach et al., 2008). Most studies involving
HO-1, even though involving different parts of the body, show that HO-1 is probably
essential for maintaining cellular homeostasis in the body. Growth retardation, anemia,
iron deposition, and vulnerability to stressful injury are all observed in HO-1 knockout.
Animals presented as HO-1 knockout normally do not survive. (Poss & Tonegawa,
1997) In addition, a similar phenotype has been observed in the one reported instance
of a human with HO-1 deficiency (Yachie, Niida et al., 1999).
Heme oxygenases have become recognized as major protective proteins. Increased
expression of HO-1 has been shown to be effective in preventing or ameliorating
pathologies associated with atherosclerosis, angioplasty, chronic allograft rejection,
inflammatory lung disease, LPS-induced endotoxemia, and ischemia reperfusion injury.
Degradation of heme not only reduces the oxidative potential within tissues, but the
products generated by the degradation of heme have potent antioxidant, antiinflammatory, anti-proliferative, and anti-apoptotic properties.
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Heme Oxygenase

CH2
H3C

H3C H2C
H
C

Fe

HC
N

HOOC

O

N

N

H3C

CH3

CH2
CH

N
H

C
H

C
O

CH2

CH3 H3C
C
H

N
H

N
H

CH

N
H

O

Biliverdin
NADPH + H+
NADP+

N
C
H

COOH

HOOC
H3C

CH3
+

Fe

H3C

H2C

O

N
H

HOOC
H3C

COOH
CH3 H3C

CH2

2

COOH

C
H

N
C
N
HH
H H
Bilirubin

Figure 3: Pathway of heme metabolism.

CH

N
H

O

16

Figure 4: Example of Research Objective:
(A) Immediately post burn: intervening space (IS); burn wound.
(B) Seven days post wounding.
(C) Seven days post wounding with treatment (Mahanjan et al., 2006)
They used 1 x 2 cm burns with 0.5 cm IS. I want to increase the IS to 1
cm.
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Methods and Materials

Burn Wound Healing of Animals Protocol

The expression and influence of HO-1 on burn wounds was tested using Wistar
male rats (Harlan Sprague Dawley, Inc., Indianapolis, IN). The standard outbred rat
weighed approximately 225 g. The animals were delivered to Sanger Hall and allowed
to acclimate to the new surroundings for about a week. Twenty four hours prior to the
wounding procedure 0.1 cc of 5 mg/kg CoPP or 0.2 cc of 30 µM/kg SnPP were
administered to the animal via intraperitoneal (I.P.) injection. The oxygen tank regulator
in the surgery room was checked in order to make sure it was full. Polyethylene glycol
pads were heated to 39°C.
On the day of the procedure, water was brought to 100°C and a thermometer
was used to monitor the temperature. A brass template (brand) specially made to wound
the rats was placed in the boiling water. Refer to Figure 4. The template was made with
three brass prongs and a wooden handle. The prongs were spaced 0.5 cm apart and each
prong was 2 cm in height and 1 cm in length. Refer to Figure 5.
Anesthesia was induced with 4-5% isofluorane at 1.0 Liter/min. Following
induction, the animal was removed from the induction chamber and placed in a nose
cone that provided 2% isofluorane at 0.5 Liter/min. A toe pinch was administered to
ensure the animal was under anesthesia. The tail was marked with a black Sharpie for
identification purposes, and 0.2 cc of 125 µg/µL buprenorphine administered
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subcutaneously (s.c.) in the skin on the back of the animal above a rear leg. Clippers
were used to remove the hair from the upper trunk region of the animal. Chemical
depiliation (Nair) was used to remove the remaining hair. Phosphate buffered saline
(PBS) pH 5.0 was used to rinse the area and neutralize the chemical depilator. The skin
was dried thoroughly.
The brand was taken out of the 100°C water, briefly dried and applied to the
skin for 45 seconds using the weight of the brand for pressure. This produced a
reproducible full-thickness burn where the brand directly touched the skin. In addition,
the two interspace regions frequently also became necrotic. In this model, the
interspace region represents a zone of stasis. A labeled ruler tape was placed beneath
the wound and a photograph was taken to document the brand. The animal was then
placed in the recovery chamber for about 10-15 minutes or until walking around and
alert, and then placed in appropriate cages. The procedure was documented on the data
sheets. As follow up, the branded animals were given 0.2cc of 125 µg/mL
buprenorphine twice a day for two days and then on days 3-7 (or until sacrificed)
provided one “cherry Jello shot” containing 75 mg of acetaminophen.
On Day 1, 3, or 7 the animals were sacrificed (Euthasol (150 mg/kg, I.P.). and in
the time it took for the Euthasol to take effect, the materials were collected: bucket of
ice, 15 mL tubes labeled appropriately, “RNALater” (25 mM sodium citrate at pH 5.2
and 25 mM EDTA), cutting board, scalpel blades, tweezers, surgical scissors, blue
chucks, camera, and ruler tape. A picture of the wound was taken labeled with ruler tape
before any surgical procedures were performed. A blue chuck was placed on the bench
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and No. 15 scalpel blades used to remove the wound from the back of the animal. Then
the wound was divided into: normal skin, not affected by the brand; direct burn; and the
interspaces between each direct burn so, three samples were taken from each animal.
See Table 1 for treatment groups. Each of these samples were harvested, minced into
1.0 mm pieces, and placed in labeled 15 mL tubes. Two sets of tissues were generated.
The first set of tubes was placed in a -70 °C. “RNALater” was added to the second set
of tubes and the samples were stored in a -20°C freezer to later be used for molecular
study.

Tissue Extraction

Proteins were extracted in manner that would be amenable for enzymatic and
immunoblotting analyses. The samples were taken out of the -70 °C freezer and
approximately 100 mg of each sample was weighed out and placed into a 15 mL
polypropylene round bottom tube. 2 mL of 1X Homogenization Buffer (25 mM Tris-Cl
pH 7.5, 0.2 M NaCl, 3.0 mM CaCl2, 0.03% Brij-35) was added and the tissue was
homogenized using a Brinkmann Polytron (PT 10/35) Homogenizer with a standard
saw tooth generator (20 Mm dia). The generator was rinsed with deionized water
before homogenization began and in between each sample in order to prevent crosscontamination. Each tissue sample was homogenized with about 15 to 20 second pulses.
The processed samples were then transferred to 1.5 ml microfuge tubes and spun at
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18,000g for 20 minutes at 4°C to clarify them. The clarified extract was then transferred
to a new 1.5ml tube for use in various enzymatic assays.

Protein Assay

The protein concentration was determined using the Bio-Rad Assay. This assay
used an acidic solution of Coomassie Brilliant Blue G-250 dye to determine the
concentration of solubilized protein in the sample. The dye binds to the protein which
shifts absorbance from 465 to 595 nm. The change in color of the dye occurs in
response to different amounts of protein.
Standard and sample wells were all set up in a 96-well plate. The standard wells
consisted of an increasing amount of bovine serum albumin (BSA), ranging from 2 g
to 24 g. Volumes were brought to 160 l with water and 1X Homogenization buffer.
BioRad protein assay reagent (40 l) was added and mixed. Wells containing samples
and standards contained identical amounts of the homogenization buffer to correct for
artifactual contribution of the homogenization buffer to the absorbance. The plate,
with the samples and standards, was then incubated and read for 5 minutes at 595 nm
using the uQuant spectrophotometer (Biotek Instruments, Inc., Winooski, VT). A
standard curve with a correlation of 0.9 or better was considered acceptable.
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Myeloperoxidase Assay

During the acute phase of inflammation, neutrophils leave the vasculature and
travel towards the site of inflammation by chemotaxis (Broughton, Janis et al., 2006).
Myeloperoxidase (MPO) is a lysosomal enzyme most abundantly located in the
cytoplasmic granules of neutrophils. This enzyme accounts for 5% of the total protein
of neutrophils and approaches 25% of the protein within the granules themselves.
Monocytes also express MPO, but these cells are much less abundant than neutrophils
and express less MPO per cell than neutrophils. Therefore, this enzyme is typically
regarded as a marker of neutrophils. This enzyme is synthesized as a single chain
precursor developed into a tetramer consisting of two light chains and two heavy chains
bound to a prosthetic heme group. MPO catalyzes the reaction of hydrogen peroxide
with chloride ions to form hypochlorous acid (HClO). (Lau, Mollnau et al., 2004;
Mathy-Hartert, Bourgeois et al., 1998)

The primary reaction in the MPO assay is:
H2O2
O- + AH2

H2O + OH2O + A

The MPO Assay uses –dianisidine dyhydrochloride (AH2) as the hydrogen
donor, which combines with the oxygen radical produced from the breakdown of
hydrogen peroxide. After this occurs, a colored compound is formed (A) which can be
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followed spectrophotometrically to quantify the amount of myeloperoxidase in the
tissue samples.
The uQuant spectrophotometer (Biotek Instruments, Inc., Winooski, VT) using
KC Junior software was turned on about twenty minutes prior to use. The reagents
needed were: stock MPO (Calbiochem) stored with 100 µg of MPO in 850 µL of PBS,
0.2 M Phosphate Buffer, and 50 mM Phosphate Buffer, hexadecyltrimethyl -ammonium
bromide (HTAB), hydrogen peroxide, 800 µM

– dianisidine dyhydrochloride. 85 µL

aliquots of MPO were removed from the -20°C as 23.5 milliunits per µL. At pH 6.0 and
25°C one unit reduces 1 µM of hydrogen peroxide per minute. The stock MPO was
diluted to 0.2 milliunit/µL. Specific amounts of MPO were added to each well of a 96
well plate. The samples were thawed and diluted to 30 µg of protein in a final volume of
150 µL of HTAB. HTAB is a detergent that was used to lyse the polymorphonuclear
(PMNs) neutrophils. The protein assay was used to determine the amount of protein
present in each sample. Since 5 µL of each samples were used in the protein assay, the
amount of protein determined was taken and divided by 5 µL. In order to dilute the
samples to 30 µg of protein in 150 µL of HTAB, 30 µg was divided by the
concentration previously determined. These calculations gave the amount (µL) of
sample needed to add to the wells. Then 50 µL of the samples with HTAB were added
to the wells. 0.25 mg of

– dianisidine dyhydrochloride was dissolved in 1 mL of 50

mM Phosphate Buffer and 50 µL was dispensed into the wells. The plate reader was set
so that kinetic reads were taken at 5 minute intervals (12 readings) at 450 nm. Lastly, 50
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µL of 0.01% hydrogen peroxide was mixed with the contents of the wells using a multipipettor, so as to read the plate as quickly as possible due to the fast reaction.

Concentration of Protein Samples Using Trichloroacetic Acid

It was necessary to further concentrate some extracts. This was accomplished
by precipitating samples with trichloroacetic acid (TCA). The reagents needed were:
100% TCA, 20% TCA, and 100% ethanol. The amount of the sample to be placed in a
1.5 mL tube was determined from the protein assay. An equal volume of 20% TCA was
added to the sample and mixed. The sample with TCA was left in the -20°C freezer for
twenty minutes. The tubes were then spun at 4°C in the microcentrifuge at maximum
speed for 15 minutes. The supernatant was carefully removed and discarded and the
pellet retained. Washing of the pellet was accomplished by adding 100 µL of ice-cold
100% ethanol. The tube was inverted a couple of times and microfuged for 5 minutes
just to ensure that the pellet was adhered to the bottom of the tube. The ethanol was then
pipetted out. The pellet was air dried in Dryer in the cold room for 5 minutes. 6X
Reducing Loading buffer used in the Western blot was diluted to 2X Loading Buffer.
The sample was then resuspended in 36 µL of the 2X Loading Buffer. 6X Reducing
Loading Buffer is composed of 3 mL [2M] of 600 mM Tris pH 6.8, 3 mL [20%] of
6.0% sodium dodecyl sulfate (SDS), 3 mL of 30% glycerol, 629 µL of 900 mM
dithiothreitol (DTT), 500 µL [1%] of 0.05% N,N -bis(2-pyridinecarboxamide)-1,2benzene dianion (BpB), q.s. to 10 mL H2O.
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Immunoblotting (Western) Using Traditional Gel System

Polyacrylamide gels form after monomeric acrylamide is polymerized. N, N’methylenebisacrylamide cross-links chains. Ammonium persulfate (AP) initiates this
reaction and tetramethylethylenediamine (TEMED) speeds it up. In discontinuous
sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE), the samples
loaded first enter the stacking gel which contains chloride ions that migrate quickly. The
electrophoresis buffer contains glycine, which are less mobile. A zone is generated
during electrophoresis that has low conductivity and therefore a high voltage gradient.
This results in stacking of proteins between the leading and trailing ions. SDS binds
most proteins in a constant weight ratio. Therefore, SDS-protein complexes migrate
through the gel according to their size. A 10% gel was used in this case because this
was appropriate for the observation of heme oxygenase.
The reagents needed were: 4X Stacking Gel Solution, 4X Resolving Gel
Solution, 10X SDS-PAGE Running Buffer, 10% AP, 30% Bis-acrylamide stock,
TEMED, 6X Loading Buffer, 10X Electroblotting Buffer, 10X Tris buffered saline
Tween-20 (TBST), lowfat dried milk, primary antibody, secondary antibody, and
chemiluminescence reagents (Perkin Elmer Lightning). 4X Stacking Gel solution is
made up of 0.5 M Trizma Base, 0.4% SDS, and deionized water. 4X Resolving Gel
solution is composed of 1.5 M Trizma Base, 0.4% SDS, and deionized water. 6X
Loading Buffer consists of 600 mM Tris pH 6.8, 6.0% SDS, 30% glycerol, 900 mM
DTT, 0.05% BpB, and deionized water. 10X Electroblotting Buffer is formed from 250
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mM Trizma Base, 1.92 M glycine, and deionized water. Lastly, 10X TBST is created
from 1.37 M NaCl, 200 mM Tris, 1% Tween, deionized water, and HCl to bring TBST
to pH 7.6.
The resolving gel was made using a 1.5 mm (10 cm x 10 cm) 10%
polyacrylamide gel. A traditional (dimensions including thickness 1.5mm) glass
cassette and casting stand assembly were set up. The resolving gel monomer solution
was prepared by combining all the reagents: 4.2 mL of deionized water, 3.3 mL of 30%
acrylamide, 2.5 mL of 4X Resolving Gel Solution, and 50 µL of 10% AP, except for the
TEMED. 1 mL of the resolving gel solution was transferred to a 1.5 mL tube and 25 µL
of TEMED was added. Immediately 0.5 mL of the solution was poured into the
assembled gel cassette acting as a plug to ensure that there were no leaks.
Polymerization occurred in about 5 minutes. Then 25 µL was added to the remaining
monomer solution and 6.7 mL was pipetted into the gel cassette and 1 mL of deionized
water was overlaid on top of the poured resolving gel solution by dialing down of the
1000 µL pipette. The gel polymerized in about 15 minutes to 30 minutes.
While the resolving gel polymerized, the 4% stacking gel solution was prepared
by combining: 3.1 mL deionized water, 0.7 mL 30% acrylamide, 1.25 mL 4X Stacking
Gel Solution, and 25 µL 10% AP. Before adding the 25 µL of TEMED the solution was
vacuumed for 5 minutes in order to eliminate oxygen to expedite polymerization. When
polymerization of the resolving gel took place, the water on top of the gel was poured
off and replaced with the stacking gel solution. After the stacking gel solution was
poured, the combs were put into place. The stacking gel was allowed to polymerize for
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about 30-45 minutes. Once polymerization had taken place, the combs were gently
removed and placed in the assembled gel cassette into the Electrophoresis Module. The
tank was filled with 1X Running Buffer. The wells were rinsed thoroughly with the 1X
Running Buffer prior to loading.
Using the protein assay concentrations of the samples, 30 µg of each sample was
transferred to a 1.5 mL tube and each sample brought to 30 l with deionized water. 6X
Loading Buffer (6 l) was added and mixed. The samples were then heated at 95°C for
5-7 minutes in a Perkin-Elmer Thermocycler. 4-6 µL of Bio-Rad Prestained protein
markers were loaded into the first lane. 30 µL of each sample was added to each
remaining well. The lid was placed on the tank, making sure that the electrodes matched
in color. The power supply was turned on and run at a constant voltage of 100 V. The
gel ran for about 90 minutes or until blue dye reached the bottom of the gel.
The electrophoresis cassette was disassembled and in a 9 inch Pyrex dish filled
with 1X Electroblot Buffer, the plates of the gel were pried apart and using a metal
spatula the gel was removed from the glass plates. Sponges and filter paper were
allowed to prewet in the 1X Electroblot Buffer. The Transblot cassette was placed in a
second 9 inch Pyrex dish and immersed black side down in the remaining 1X
Electroblot Buffer. On the black side of the cassette, a sponge, one paper filter, gel,
polyvinylidene fluoride (PVDF) transfer membrane, one paper filter, and one sponge
were set up. The PVDF membrane was first dipped in methanol due to the membrane
being highly hydrophobic. The cassette was then placed into the transblot tank that
contained an ice pack and a stirring bar. The transblot tank was set on a magnetic plate
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and filled almost to the top with 1X Electroblot Buffer. The lid was put on and the
electrodes were plugged into the power supply. The power supply was set to constant
current at 400 mA with the unit producing about 100-125 V. The transfer went for 1
hour. The cassette was removed and the side of the membrane touching the gel was
labeled with a soft lead pencil. The two pink bands of the marker were labeled and a
form of ID was written on the membrane.
The membrane was blocked for 1 hour at room temperature with continual
agitation with about 20 mL of 5% milk in 1X TBST. From this point on the membrane
never became dry. The block was removed and rinsed quickly with 1X TBST. The
primary antibody was diluted appropriately in 1X TBST and approximately 10 mL was
added to the membrane. The membrane in the primary antibody was then incubated
overnight at 4°C with continual rocking.
The next day the primary antibody was removed and stored at -20°C freezer and
was reused several times. The membrane was washed in 1X TBST four times for 5
minutes each with 25-50 mL of 1X TBST. During the washes, the secondary antibody
was diluted appropriately in 1X TBST and added to the membrane. The membrane was
incubated in the secondary antibody at room temperature with continual rocking for 1
hour. The secondary antibody was removed and discarded. The membrane was again
washed in 1X TBST 4 times for 5 minutes each. During the final wash, 5 mL of each of
the Perkin Elmer luminal and substrate solutions were mixed (total 10 mL). After the
last wash, the membrane was immersed in the luminal and substrate solution.
Immediately following, the membrane was wrapped in plastic wrap and placed in a film
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cassette with fluorescent crayon labels. The membrane was exposed to autorad film for
5-30 minutes and developed.

Gelatin Zymography

Gelatin zymography was used to reveal the presence of the matrix
metalloprotienases (MMP), MMP-2 and MMP-9. Gelatinases are resolved by SDSPAGE, after renaturing, the gelatinases degrade the gelatin substrate that was
copolymerized into the gel. Staining with Coomasie Blue results in clear zones on the
gel in the midst of a dark background. The zones of clearing represent areas in which
the gelatin was degraded.
The reagents needed were: 4X Stacking Gel Solution, 4X Resolving Gel
Solution, 10X SDS-PAGE Running Buffer, 10% AP, 30% Bis-acrylamide stock,
10mg/mL Gelatin, TEMED, 6X Non-Reducing Loading Buffer, 2.5% Triton X-100,
10X MMP Buffer, 0.1% Coomasie Blue, and 10% acetic acid-10% ethanol.
The resolving gel was made using a 1.5 mm (10 cm x 10 cm) 10% acrylamide
gel. A traditional glass cassette and casting stand assembly were set up. The resolving
gel monomer solution was prepared by combining all the reagents: 3.2 mL of deionized
water, 3.3 mL of 30% acrylamide, 2.5 mL of 4X Resolving Gel Solution, 1.0 mL of 10
mg/mL Gelatin, and 50 µL of 10% AP, except for the TEMED. 1 mL of the resolving
gel solution was transferred to a 1.5 mL tube and 25 µL of TEMED was added.
Immediately 0.5 mL of the solution was poured into the assembled gel cassette acting as
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a plug to ensure that there were no leaks. Polymerization occurred in about 5 minutes.
Then 25 µL of TEMED was added to the remaining monomer solution and 6.7 mL was
pipetted into the gel cassette and 1 mL of deionized water was overlaid on top of the
poured resolving gel solution by dialing down of the 1000 µL pipette. The gel
polymerized in about 15 to 30 minutes.
While the resolving gel polymerized, the 4% stacking gel solution was prepared
by combining: 3.1 mL deionized water, 0.7 mL 30% acrylamide, 1.25 mL 4X Stacking
Gel Solution, and 25 µL 10% ammonium persulfate. Before adding the 25 µL of
TEMED the solution was vacuumed for 5 minutes in order to eliminate oxygen to
expedite polymerization. When polymerization of the resolving gel took place, the
water on top of the gel was poured off and replaced with the stacking gel solution. After
the stacking gel solution was poured, the combs were put into place. The stacking gel
was allowed to polymerize for about 30-45 minutes. Once polymerization had taken
place, the combs were gently removed and placed in the assembled gel cassette into the
Electrophoresis Module. The tank was filled with 1X Running Buffer. The wells were
rinsed thoroughly with the 1X Running Buffer prior to loading.
Using the protein assay concentrations of the samples, 30 µg of each sample was
transferred to a 1.5 mL tube and each sample had the appropriate amount of deionized
water added, so that the same volume was added to each well. Then 1/5 volume of 6X
Non- Reducing Loading Buffer was added. 4-6 µL of Bio-Rad Prestained protein
markers were loaded into the first lane with 26 µL of tissue sample chosen due to high
levels of protein. This addition of the same tissue sample with marker to each gel
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allowed for a normalization of gel to gel variations. 30 µL of each sample was added to
each remaining well. The lid was placed on the tank, making sure that the electrodes
matched in color. The power supply was turned on and run at a constant voltage of 100
V. The gel ran for about 90 minutes or until blue dye reached the bottom of the gel.
The electrophoresis cassette was disassembled and in a 9 inch Pyrex dish filled
with 2.5% Triton X-100, the plates of the zymogram were pried apart and using a metal
spatula the zymogram was removed from the glass plates. A notch was made in the top
corner of the zymogram that contained the marker. Notches were also made at the pink
bands from the marker. Then the zymograms were incubated in the 2.5% Triton X-100
for 30 minutes each at room temperature on the rocker. This incubation was done twice.
10 X MMP Buffer was diluted to 1X MMP Buffer which consisted of 25 mM Tris –Cl
pH 7.5, 200 mM NaCl, 3 mM CaCl2, and 0.3% Brij – 35. 1X MMP Buffer was used to
incubate the zymogram overnight at 37°C on the rocker.
The zymogram was removed from the 1X MMP Buffer and stained with 0.1%
Coomasie Blue in 10% acetic acid and 10% ethanol for 2-4 hours on the rocker at room
temperature. Destaining was done with 10% acetic acid-10% ethanol for about 1-2
hours on the rocker at room temperature. Kim-Wipes were placed in the corner of the
containers in order to speed up the destaining process. When zones of clearing were
very apparent, the zymogram was removed from the destaining solution and a picture
was taken using a digital camera. The settings of the digital camera were consistent
throughout the documenting of the zymograms: macro setting, no flash, and ISO 200
using a light box.
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Assay for Collagenolytic Activity

Collagen consists of a triple helical structure. Active collagenase is an enzyme
that cleaves collagen. Collagenase breaks collagen into two TCA fragments. Above
30°C the two fragments of collagen will denature. This particular assay shows the two
fragments on the gel due to utilization of radioactive collagen. Fluorography is used for
detecting the radioactive labeled collagen activity in the assay. Radiation is emitted
from substances in this case collagen that are radioactively labeled. This radiation
excites a molecule, also known as a fluor, in the gel. The excited fluor then relaxes back
down to the ground state and emits a photon of visible light that is detected by a film.
Then the film is developed and the bands are portrayed. This technique allows for
increased sensitivity to weak radiation signals. (Waterborg et al., 1994; Laskey, 2003)
The reagents needed were: dialyzed 14C labeled collagen (Type I), 10X MMP
Buffer, 500 mM EDTA, 50 mM aminophenylmercuric acetate (APMA) made fresh in
0.1 N NaOH, 6% SDS-PAGE gel, 6X Reducing Loading Buffer, 10% acetic acid-10%
ethanol, and Amplify.
Master mixes were set up on ice using 0.5 mL microfuge tubes. There were
three tubes per sample: negative, active, and total. The negative contained 30 µL of 1X
MMP Buffer, 20 µL of sample, 2 µL of ethylenediamene tetraacedic acid (EDTA), and
50 µL of 14C-collagen. The active contained 30 µL of 1X MMP Buffer, 20 µL of
sample, and 50 µL of 14C-collagen. The total contained 30 µL of 1X MMP Buffer, 20
µL of sample, 3 µL of aminophenylmercuric acetate (APMA), and 50 µL of 14C

32

-collagen. Once these samples were prepared, they were placed in the Thermocycler at
30°C for 1 hour, 4 hours, and overnight. After 1 hour a 30 µL aliquot was taken out and
added to a new tube containing 6 µL of 6X Reducing Loading Buffer to stop the
reaction. This same aliquot was done after 4 hours and then overnight. The tubes taken
out after 1 hour and 4 hours were then stored at -20°C until the last aliquot was
collected. When all the aliquots were ready to be run, a 6% SDS-PAGE gel was made.
The resolving gel was made using a 1.5 mm (10 cm x 10 cm) 6% acrylamide
gel. A traditional glass cassette and casting stand assembly were set up. The resolving
gel monomer solution was prepared by combining all the reagents: 5.5 mL of deionized
water, 2.0 mL of 30% acrylamide, 2.5 mL of 4X Resolving Gel Solution, and 50 µL of
10% AP, except for the TEMED. 1 mL of the resolving gel solution was transferred to a
1.5 mL tube and 25 µL of TEMED was added. Immediately 0.5 mL of the solution was
poured into the assembled gel cassette acting as a plug to ensure that there were no
leaks. Polymerization occurred in about 5 minutes. Then 25 µL was added to the
remaining monomer solution and 6.7 mL was pipetted into the gel cassette and 1 mL of
deionized water was overlaid on top of the poured resolving gel solution by dialing
down of the 1000 µL pipette. The gel polymerized in about 15 to 30 minutes.
While the resolving gel polymerized, the 4% stacking gel solution was prepared
by combining: 3.1 mL deionized water, 0.7 mL 30% acrylamide, 1.25 mL 4X Stacking
Gel Solution, and 25 µL 10% ammonium persulfate. Before adding the 25 µL of
TEMED the solution was vacuumed for 5 minutes in order to eliminate oxygen to
expedite polymerization. When polymerization of the resolving gel took place, the
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water on top of the gel was poured off and replaced with the stacking gel solution. After
the stacking gel solution was poured, the combs were put into place. The stacking gel
was allowed to polymerize for about 30-45 minutes. Once polymerization had taken
place, the combs were gently removed and placed in the assembled gel cassette into the
Electrophoresis Module. The tank was filled with 1X Running Buffer. The wells were
rinsed thoroughly with the 1X Running Buffer prior to loading.
The samples were heated at 95°C for 5 minutes and run on the gel with 30 µL of
sample per well using 4-6 µL of marker in Lane 1 only. The gel was electrophoresed at
100 V for about 45 minutes. The gels were removed from the glass and fixed in 10%
acetic acid-10% ethanol for 10-15 minutes at rocker on room temperature or until the
dark blue band at the bottom of the gel turned a yellow color. The gels were then
incubated in about 25 mL of Amplify for 20 minutes on the rocker at room temperature.
About 45 minutes prior to gel drying, the gel dryer was turned on. The gels were placed
on two sheets of filter paper, covered with saran wrap, and placed on the dryer for 1
hour. Immediately following, the gel was wrapped in plastic wrap and placed in a film
cassette with fluorescent crayon labels. The gel was exposed to film for about 2 days in
the -70°C freezer and developed.
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Template for Burn
Induction
Non-thermo conducting
(e.g., wood)handle

Thermocouple
(optional)

Machined
Aluminum 6061 T6
0.375” by 0.75”
Long and short strips that
are screwed together?

5.0cm

2.0cm
1.0cm

1.0cm
5.0cm

Figure 4: Template for Burn Wound
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Table 1: Treatment Groups for Burn Wounding

Treatment Groups
Groups

Treatment

Day 1

Day 3

Day 7

1

Burned, untreated

N=8

n=7

n=7

2

Burned, 5mg/kg CoPP

N=8

n=7

n=7

3

Burned, 30 M/kg SnPP

N=7

n=7

n=9
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Results

Surgery and Animal Survival

Full-thickness thermal injury was generated using an established procedure with
some modification (Ehrlich et al., 1992). In the original model, a brass probe consisting
of a 55 x 19 mm rectangle with three 5 mm wide transverse notches was used to
generate a row of four 10 x 19 mm full-thickness burns. Because of the size of this
probe, it was found to be difficult to achieve a relative uniform burn. Therefore, the
probe used in this study was modified to consist of a 40 mm x 20mm rectangle
containing two 5 mm-wide transverse notches.
A pilot was performed on a small group of animals to establish optimal contact
time required for obtaining a reproducible full-thickness thermal injury with minimal
involvement of the underlying muscle. Animals were anesthetized with inhalant
isoflurane and provided buprenorphine analgesia subcutaneously (sc). A rectangular
brass probe was equilibrated to 100°C. The heated probe was applied to the depilated
back of the anesthetized animals. Probes were allowed to “balance” on the skin for 30,
35, 40, and 45 seconds before removing. The wounds were examined on days post
wounding 1 and 3. It was determined that application of the probe for 45 seconds
achieved the desired burn severity. This procedure was used on all 54 animals in this
study. Mortality was less than 2% (1/54). The total surface area of the burn injury was
less than 4% of total body surface area.
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On some occasions, while using the Nair product to eliminate the rats’ hair prior
to injury, all the hair was not completely removed. This could have had a slight effect
on the small differences between burn wounds.
The rats were examined twice daily and to provide analgesia. All of the animals
appeared normal, alert, and experiencing little pain given that pain medications were
administered daily. Documentation of the injury on the animals was made daily. The
majority of the animals did not seem to aggravate their wounds and only very few
appeared to be worse after healing should have already set in. A picture was taken
immediately after each animal was injured. Wounds were also photo-documented on
sacrifice Day 1, Day 3, and Day 7 following injury. See Figure 6. Following euthansia,
normal skin, skin subjected to direct application of the probe (direct) and skin
representing the interspace was harvested. Tissues were bisected with portions snap
frozen and stored at -70°C or placed in “RNALater” and stored at -20°C.

Measurement of Burn Conversion

Areas of necrosis within the interspace regions of wounds taken at harvest were
determined by planimetry using SigmaScan. Each photograph was calibrated using a
size reference placed on each wound. Areas of frank necrosis were then determined.
As can be seen in figure 7, in general, wounds in animals treated with Co PP contained
smaller areas of frank necrosis than either the Sn PP or untreated groups. For the Co PP
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treated group, there was a statistically significant difference (p<0.05, ANOVA, Tukeys)
on days 3 and 7 compared to either of the other two groups.
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Figure 6: Representative Burns on Days 0, 1, 3, and 7 Post Wounding

40

Necrosis in Interspace
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SnPP
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Figure 7: Mean Levels of Necrosis
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BCA Assay for Protein Concentration

Tissues were thawed on ice and then extracted as described in the Methods.
Concentrations of protein extracts were determined using the bicinchoninic acid protein
assay using bovine serum albumin to generate a standard curve. This assay has been
adapted to a 96-well format to minimize consumption of materials. The protein standard
curve shown in figure 8 on page 42 was very accurate from 2 – 24 µg. There was one
point (under 2 µg) on the standard curve that appeared to not be consistent with the rest
of the points, but when taking that specific point out; the R-squared value became
0.9894. R2 = 1 is considered to be a perfect standard curve. This assay showed that there
was an abundant amount of protein in the samples. By ensuring that protein was in each
sample, the multitudes of subsequent tests were able to be performed.
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Figure 8: Protein Assay Standard Curve Generated from Tissue Samples; the curve was
linear between 2 and 24 µg of protein
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Western Blot for Heme Oxygenase - 1 Levels
The heme oxygenase – 1 protein levels were determined using immunoblotting.
HO-1 migrated as a 32 kDa protein. A composite of HO-1 expression on Day 1 is
shown in figure 9. In animals not treated with heavy metal protoporphyrins there is no
detectable expression of HO-1 in non-burned skin. In contrast there is significant
expression of HO-1 in the interspace region. This was expected as HO-1 is a stress
response protein. Typically, there were lower levels of HO-1 present in tissues
representing full-thickness burns. As these tissues are nonviable, this was an expected
outcome. HO-1 expression in tissues from animals treated with either heavy metal
protoporphyrin revealed a significantly different pattern. As expected, heavy metal
protoporphyrins induced global expression of HO-1. Somewhat unexpectedly, HO-1
levels were consistently higher in tissues from animals treated with Co PP than with Sn
PP (Figures 10-12). In vitro studies in this laboratory have demonstrated that carbon
monoxide, one of the products generated by HO-1, can act in a positive feedback
manner on HO-1 expression (Kulina, R., 2008). Thus, the higher levels observed in
animals treated with Co PP may be explained by this. A less likely explanation is that
Co PP’s ability to inhibit necrosis may in turn permit greater expression of HO-1.
However, the differential response to the heavy metal protoporphyrins is observed in
non-burned tissues (Figure 11). Statistical analysis was achieved using the program,
SigmaStat. ANOVA (Tukeys) tests were performed for direct burn tissue, non-burned
tissue, and interspace tissue. See Tables 2-4.
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Beginning with tissue samples from the directly burned skin on Day 1 and Day
3 showed similar results. Cobalt PP HO – 1 levels were the highest, while in the control
groups, the lowest levels were observed. Tin PP showed HO – 1 levels mid – range and
the untreated animals had the lowest levels of HO – 1. The amount of HO – 1 was
greater in every group on Day 3 compared to Day 1. The final surgery day, Day 7,
showed the cobalt PP group with the highest levels of HO – 1, which appears to be very
consistent. The untreated group has fairly high levels of HO – 1. Lastly, the tin PP
treated animals had the lowest amount of HO – 1.
Skin tissue samples (uninjured tissue) on Day 1, the animals treated with cobalt
PP had the highest level of HO – 1. Untreated animals had the lowest concentration of
HO – 1 and the animals treated with tin PP also had very low levels. Day 3 skin HO – 1
level was again highest in cobalt PP and lowest in non – treated animals. The HO – 1
level for Tin PP were slightly higher than those for Day 1, but again low. Lastly, the HO
– 1 levels for skin Day 7 again had cobalt PP treated animals with the highest
concentration, but tin PP with the lowest concentration. The non – treated animals had
an increase compared to Day 1 and Day 3.
The interspace tissue samples for Day 1 and Day 3 show the highest level of
heme oxygenase – 1 in the tissue treated with cobalt PP. The lowest level of HO – 1 is
apparent in the control group and tin PP HO – 1 levels ranged in the middle of the
control and cobalt PP treated animals. Although, Day 3 tin PP HO – 1 levels were
slightly higher than those of Day 1. The interspace samples for Day 7 were slightly
different. The tissue treated with cobalt PP again had the highest level of HO – 1. Tin
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PP had the lowest level of HO – 1 and the untreated animals showed the middle range
of HO – 1 levels.
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Figure 10: HO-1 Protein Levels in Full-thickness Burns
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Table 2: Statistical Analysis (ANOVA) for HO-1 Levels in Direct Burn Tissues
One Way Analysis of Variance

Thursday, December 11, 2008, 19:26:45

Data source: Data 1 in Notebook
Normality Test:

Passed (P = 0.061)

Equal Variance Test:

Failed (P = 0.035)

Test execution ended by user request, ANOVA on Ranks begun
Kruskal-Wallis One Way Analysis of Variance on Ranks
11, 2008, 19:26:45
Data source: Data 1 in Notebook
Group
Control Day 1
Cobalt Day 1
Tin Day 1
Control Day 3
Cobalt Day 3
Tin Day 3
Control Day 7
Cobalt Day 7
Tin Day 7

N
8
8
7
7
7
7
7
7
6

Missing
0
0
0
0
0
0
0
0
0

Group
Control Day 1
Cobalt Day 1
Tin Day 1
Control Day 3
Cobalt Day 3
Tin Day 3
Control Day 7
Cobalt Day 7
Tin Day 7

Median
8397.000
68063.500
27057.000
4042.000
43827.000
13265.000
68678.000
84808.000
40430.000

25%
3072.000
42127.500
16770.250
1992.750
20439.250
9340.500
30986.000
81665.000
32044.000

75%
14675.500
108685.000
39450.500
8368.750
50667.250
39747.750
78767.000
91055.500
54506.000

H = 39.032 with 8 degrees of freedom. (P = <0.001)

Thursday, December

49

The differences in the median values among the treatment groups are greater than
would be expected by chance; there is a statistically significant difference (P = <0.001)
To isolate the group or groups that differ from the others use a multiple comparison
procedure.
All Pairwise Multiple Comparison Procedures (Dunn'
s Method):
Comparison
Cobalt Day 7 vs Control Day 3
Cobalt Day 7 vs Control Day 1
Cobalt Day 7 vs Tin Day 3
Cobalt Day 7 vs Tin Day 1
Cobalt Day 7 vs Tin Day 7
Cobalt Day 7 vs Cobalt Day 3
Cobalt Day 7 vs Control Day 7
Cobalt Day 7 vs Cobalt Day 1
Cobalt Day 1 vs Control Day 3
Cobalt Day 1 vs Control Day 1

Diff of Ranks p
45.429
9
43.196
8
31.429
7
29.429
6
23.238
5
21.000
4
14.143
3
8.196
2
37.232
8
35.000
7

Q
4.565
4.483
3.158
2.957
2.243
2.110
1.421
0.851
3.864
3.760

P<0.05
Yes
Yes
No
No Test Needed
No Test Needed
No Test Needed
No Test Needed
No Test Needed
Yes
Yes
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Figure 11: HO-1 Protein Levels in Unburned Skin
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Table 3: Statistical Analysis (ANOVA) for HO-1 Levels in Unburned Tissues
One Way Analysis of Variance

Thursday, December 11, 2008, 19:46:21

Data source: Data 1 in Notebook
Normality Test:

Failed (P = <0.001)

Test execution ended by user request, ANOVA on Ranks begun
Kruskal-Wallis One Way Analysis of Variance on Ranks
11, 2008, 19:46:21

Thursday, December

Data source: Data 1 in Notebook
Group
Control Day 1
Cobalt Day 1
Tin Day 1
Control Day 3
Cobalt Day 3
Tin Day 3
Control Day 7
Cobalt Day 7
Tin Day 7

N
8
8
7
7
7
7
7
7
6

Missing
0
0
0
0
0
0
0
0
0

Group
Control Day 1
Cobalt Day 1
Tin Day 1
Control Day 3
Cobalt Day 3
Tin Day 3
Control Day 7
Cobalt Day 7
Tin Day 7

Median
1673.000
84846.500
6999.000
830.000
23963.000
5255.000
15304.000
47388.000
1672.500

25%
1148.000
73776.000
3667.500
459.500
5013.250
2406.250
6636.250
36323.000
0.000

75%
3236.500
87035.000
12697.750
2020.750
31789.000
9653.500
25079.250
62480.500
3437.000

H = 45.610 with 8 degrees of freedom. (P = <0.001)
The differences in the median values among the treatment groups are greater than
would be expected by chance; there is a statistically significant difference (P = <0.001)
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To isolate the group or groups that differ from the others use a multiple comparison
procedure.
All Pairwise Multiple Comparison Procedures (Dunn'
s Method):
Comparison
Cobalt Day 1 vs Control Day 3
Cobalt Day 1 vs Control Day 1
Cobalt Day 1 vs Tin Day 7
Cobalt Day 1 vs Tin Day 3
Cobalt Day 1 vs Tin Day 1
Cobalt Day 1 vs Cobalt Day 3
Cobalt Day 1 vs Control Day 7
Cobalt Day 1 vs Cobalt Day 7
Cobalt Day 7 vs Control Day 3
Cobalt Day 7 vs Control Day 1
Cobalt Day 7 vs Tin Day 7
Cobalt Day 7 vs Tin Day 3

Diff of Ranks p
47.393
9
42.500
8
42.250
7
31.821
6
25.393
5
21.107
4
18.250
3
6.679
2
40.714
8
35.821
7
35.571
6
25.143
5

Q
4.918
4.565
4.202
3.302
2.635
2.190
1.894
0.693
4.091
3.717
3.434
2.526

P<0.05
Yes
Yes
Yes
Yes
No
No Test Needed
No Test Needed
No Test Needed
Yes
Yes
Yes
No
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Figure 12: HO-1 Protein Levels in Interspace Tissues
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Table 4: Statistical Analysis (ANOVA) for HO-1 Levels in Interspace Tissue
One Way Analysis of Variance

Thursday, December 11, 2008, 20:10:49

Data source: Data 1 in Notebook
Normality Test:

Passed (P = 0.168)

Equal Variance Test:

Passed (P = 0.062)

Group
Control Day 1
Cobalt Day 1
Tin Day 1
Control Day 3
Cobalt Day 3
Tin Day 3
Control Day 7
Cobalt Day 7
Tin Day 7

N
8
8
7
7
7
7
7
7
6

Missing
0
0
0
0
0
0
0
0
0

Group
Control Day 1
Cobalt Day 1
Tin Day 1
Control Day 3
Cobalt Day 3
Tin Day 3
Control Day 7
Cobalt Day 7
Tin Day 7

Mean
19666.000
52713.750
34347.143
4236.571
41902.857
32908.571
49755.286
70471.143
42003.167

Std Dev
12095.603
29197.309
18103.927
4643.180
13852.335
31924.946
43532.157
16860.181
22585.685

SEM
4276.441
10322.808
6842.641
1754.957
5235.691
12066.496
16453.609
6372.549
9220.567

Power of performed test with alpha = 0.050: 0.971
Source of Variation
Between Treatments
Residual
Total

DF
8
55
63

SS
MS
F
P
21207898335.238 2650987291.905 4.559 <0.001
31980361643.762 581461120.796
53188259979.000

The differences in the mean values among the treatment groups are greater than would
be expected by chance; there is a statistically significant difference (P = <0.001).
All Pairwise Multiple Comparison Procedures (Tukey Test):
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Comparisons for factor:
Comparison
Cobalt Day 7 vs. Control Day 3
Cobalt Day 7 vs. Control Day 1
Cobalt Day 7 vs. Tin Day 3
Cobalt Day 7 vs. Tin Day 1
Cobalt Day 7 vs. Cobalt Day 3
Cobalt Day 7 vs. Tin Day 7
Cobalt Day 7 vs. Control Day 7
Cobalt Day 7 vs. Cobalt Day 1
Cobalt Day 1 vs. Control Day 3
Cobalt Day 1 vs. Control Day 1
Cobalt Day 1 vs. Tin Day 3
Cobalt Day 1 vs. Tin Day 1
Cobalt Day 1 vs. Cobalt Day 3

Diff of Means
66234.571
50805.143
37562.571
36124.000
28568.286
28467.976
20715.857
17757.393
48477.179
33047.750
19805.179
18366.607
10810.893

p
9
9
9
9
9
9
9
9
9
9
9
9
9

q
7.267
5.757
4.121
3.964
3.135
3.001
2.273
2.012
5.493
3.876
2.244
2.081
1.225

P<0.05
Yes
Yes
No
No
No
No
No
No
Yes
No
No
No
No
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Inflammation (Myeloperoxidase and MMP Levels)

The myeloperoxidase (MPO) assay was used to provide an indication of the
amount of neutrophils located in tissue. In response to injury, neutrophils are recruited
to the site of trauma. Neutrophils contain granules which hold myeloperoxidase. MPO
accounts for 5% of the total protein content of neutrophils. This enzyme is also found
in lesser amounts in monocytes. MPO specifically converts hydrogen peroxide to
hypohalous acids in order to prevent neutrophils from apoptosis. This assay was used to
determine neutrophil levels and thus provide an indication of inflammation in each
group of tissue: skin, interspace, and direct. A representative standard curve using
purified neutrophil MPO is shown in figure 13.
MPO activity in the skin samples at all three time points was very low and
consistent with almost all the samples. The data ranged from -12.4 milliunits/mg to 1.2
milliunits/mg with one exception at 8.8 milliunits/mg. From 0 to 80 milliunits of MPO
the assay was linear with a R – squared value of 0.9841.
In contrast to the skin, MPO activity in the interspace samples was high (figure
14). Statistical analysis was achieved using ANOVA (Tukey) test. See Table 5. MPO
levels ranged from 9.6 milliunits/mg to 583.0 milliunits/mg. The R – squared value was
0.9957. Due to some of these extremely high data, certain samples significantly over
200 milliunits/mg were recalculated. By diluting specific tissue samples, another assay
was performed in order to show more accurate results. The data ranged from 1.2
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milliunits/mg to 253.3 milliunits/mg with only two outliers in the negative. The R –
squared value for the recalculated data was 0.9904.
Lastly, the activity in the direct samples was high. The R – squared value for the
graphed data was 0.9949. The data ranged from 9.6 milliunits/mg to 464.0
milliunits/mg. The last four points were taken out of the data just as in the skin samples
because when adding 0.1% hydrogen peroxide due to human error, the reaction
occurred too quickly before being placed in the spectrometer and therefore skewed the
data. Just as in the interspace samples, specific samples were recalculated due to
extremely high levels of MPO and were diluted to increase the accuracy of results. The
recalculated data ranged from -2.9 milliunits/mg to 66.1 milliunits/mg. The R – squared
value for the recalculated data was 0.9879.
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Figure 13: Representative Myeloperoxidase Standard Curve
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Figure 14: Mean Myeloperoxidase Activities in Interspace Tissues
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Table 5: Statistical Analysis (ANOVA) for MPO Assay Interspace Tissues
One Way Analysis of Variance

Friday, December 12, 2008, 11:09:42

Data source: Data 1 in Notebook
Normality Test:

Failed (P = 0.012)

Test execution ended by user request, ANOVA on Ranks begun
Kruskal-Wallis One Way Analysis of Variance on Ranks
12, 2008, 11:09:42

Friday,

December

Data source: Data 1 in Notebook
Group
Control Day 1
Tin Day1
Cobalt Day 1
Control Day 3
Tin Day 3
Cobalt Day 3
Control Day 7
Tin Day 7
Cobalt Day 7

N
8
7
8
7
7
7
7
6
7

Missing
0
0
0
0
0
0
0
0
0

Group
Control Day 1
Tin Day1
Cobalt Day 1
Control Day 3
Tin Day 3
Cobalt Day 3
Control Day 7
Tin Day 7
Cobalt Day 7

Median
2.570
1.970
2.835
2.010
3.020
1.830
2.070
3.060
1.070

25%
1.590
1.333
1.310
0.665
2.700
1.293
1.875
2.130
0.498

75%
3.595
2.820
4.750
2.945
3.460
2.885
2.543
3.440
1.948

H = 14.802 with 8 degrees of freedom. (P = 0.063)
The differences in the median values among the treatment groups are not great enough
to exclude the possibility that the difference is due to random sampling variability; there
is not a statistically significant difference (P = 0.063)
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Gelatin zymography is used to study certain enzymes in tissues and cells that
degrade extracellular matrix. The enzymes of particular interest in this study are
MMP’s, specifically MMP – 9. MMP’s degrade the gelatin that was added into the gel.
Using the Coomasie Blue dye, the clear zones in the gel are exposed showing enzymes
capable of degrading the gelatin. When analyzing the zymograms, there are two bands
that appear on the gels that represent the presence of MMP – 9. The top band portrays
the latency or pro form of MMP - 9, while the bottom band portrays the active form. By
observing the data, it was determined that by averaging the intensities of both bands
using densitometric scoring in SigmaScan gave the most accurate results. Each intensity
was normalized using the background on each gel corresponding with the samples. A
standard graph was generated using a sample that had such a large amount of enzyme.
The specific sample used with the normal 30 µg sample blew out the lane on the gel,
which means degraded almost the whole lane. Smaller and smaller increments of this
specific tissue sample were used to create the standard. See Figure 15.
The two standards showed a very consistent set of data. This gave a high
confidence that the zymograms carried out were giving accurate results. Only a select
few skin and direct tissue samples were analyzed, whereas all interspace samples were
evaluated.
In the skin tissue samples, Day 1, 3, and 7 all showed the highest level of MMP
– 9 in the control (untreated) samples. Day 1 showed Co PP and Sn PP treated had the
same levels of MMP – 9. Day 3 had Co PP treated tissue trailing slightly behind the
untreated group. The Sn PP treated group on Day 3 was also high, but had the lowest
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levels of MMP – 9 compared to the other groups. Day 7 showed the Co PP treated
tissue with the lowest levels and Sn PP levels high, but not has high as the untreated
group. In the untreated skin tissue, MMP – 9 levels were fairly high and around the
same for each day. There was not much fluctuation. The Co PP treated tissue had the
highest levels of MMP – 9 on Day 3 and the lowest levels on Day 7. Sn PP treated
samples had the highest levels of MMP – 9 on Day 7 and the lowest levels on Day 1.
Moving on to the direct tissue samples, Day 1 showed that the untreated group
again had the highest levels of MMP – 9 and Sn PP had the smallest amount of MMP –
9. Day 3 presented the complete opposite: Sn PP with highest MMP – 9 and untreated
with the lowest. Day 7 demonstrated that the tin PP group had the highest level of
enzyme and the untreated and Co PP groups had very similar levels of MMP – 9. The
untreated samples were highest on Day 1 and lowest on Day 3. The Co PP group levels
were highest on Day 1 and lowest on Day 7. Lastly, the Co PP group levels were
highest on Day 7 and lowest on Day 1.
Interspace tissue samples showed lower levels of MMP – 9 in general compared
with skin and direct tissues. Day 1 groups had very similar levels of enzyme with the Sn
PP group highest and untreated animals with the lowest levels. The same trend appeared
for Day 3 that was seen in Day 1. Day 7 portrayed different results. The Sn PP treated
samples had the highest levels of MMP – 9 and the Co PP group had the lowest. The
untreated group, Co PP treated group, and Sn PP treated group were all highest on Day
3 and lowest on Day 7. See Figure 16. Statistical analysis was acheived using the
program, SigmaStat. An ANOVA (Tukeys) test was performed. See Table 6.
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Figure 15: Linear Relationship Between Matrix Metalloproteinase-9 Levels and
Densitometry. Serial 2-fold dilutions of a single sample were subjected to gelatin
zymography. This is a log vs. log plot. Results indicate that the zones of clearing have
linear dependency with MMP-9 concentration.
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Figure 16: Gelatin Zymography of Interspace Tissues
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Table 6: Statistical Analysis (ANOVA) for Gelatin Zymography Interspace Tissues
One Way Analysis of Variance

Thursday, December 11, 2008, 18:02:10

Data source: Data 1 in Notebook
Normality Test:

Failed (P = 0.024)

Test execution ended by user request, ANOVA on Ranks begun
Kruskal-Wallis One Way Analysis of Variance on Ranks
11, 2008, 18:02:10

Thursday, December

Data source: Data 1 in Notebook
Group
Control Day 1
Cobalt Day 1
Tin Day 1
Control Day 3
Cobalt Day 3
Tin Day 3
Control Day 7
Cobalt Day 7
Tin Day 7

N
8
8
7
7
7
7
7
7
6

Missing
0
0
0
0
0
0
0
0
0

Group
Control Day 1
Cobalt Day 1
Tin Day 1
Control Day 3
Cobalt Day 3
Tin Day 3
Control Day 7
Cobalt Day 7
Tin Day 7

Median
181798.500
201503.500
232309.000
181456.000
160583.000
236226.000
276065.000
185773.000
372996.500

25%
122575.000
132543.500
137981.000
137962.500
92673.250
180620.000
157940.250
161727.750
181368.000

75%
257089.000
284487.500
301698.000
268782.750
216154.750
249004.000
328486.000
268342.500
584495.000

H = 8.673 with 8 degrees of freedom. (P = 0.371)
The differences in the median values among the treatment groups are not great enough
to exclude the possibility that the difference is due to random sampling variability; there
is not a statistically significant difference (P = 0.371)
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Collagenase Assay

Collagenase is an enzyme that cleaves collagen into two fragments. At certain
temperatures, the two fragments formed will denature. The radioactive collagen type I
used will fluoresce to detect activity.
The tissue samples used in these assays did not show any cleavage of collagen.
The wound fluid was used in every assay as a common standard. This wound fluid
would show the two fragments of collagen on each assay, and the hope was to see these
fragments in certain tissues. The reason these fragments did not show up is unknown.
The tissues may have been sitting for too long since this was the last test performed, but
it is hard to tell. Neither treatment options nor days of harvest made a difference in the
tissue samples pertaining to the collagenase assay. By observing figures 17-19, the only
fragments observed on the all assays were the wound fluid samples.
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Figure 17 : Collagenase Activity Assay 1
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Figure 18: Collagenase Activity Assay 2
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Figure 19: Collagenase Activity Assay 3
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Discussion

Burn wound conversion is an ongoing struggle for physicians and their burn
patients. Research is being conducted in order to try and understand the mechanics of
burn conversion and methods that can help to prevent it. This study examined the ability
of two heavy metal protoporphyrins to modulate burn wound conversion in an animal
model. Heavy metal protoporphyrins are modulators of the expression or activity of
HO-1. Both Co PP and Sn PP induced the expression of HO-1 at the protein level. Sn
PP is also an effective inhibitor of HO-1 activity. Animals receiving a single bolus of
Co PP 24 hrs prior to burn injury exhibited significantly less necrosis than either of the
other two groups.
In general, levels of inflammation within the interspace region as reflected by
MPO activity and MMP-9 zymography correlated with levels of necrosis. Attempts at
assessing collagenolytic activity were not successful. Neutrophil collagenase (MMP-8)
is abundant in human neutrophils and wound fluid obtained from a human chronic
wound contained easily detectable levels collagenolytic activity.
This research model was conducted using rats. The downside to this is that
factors tested in rats cannot be directly compared to humans. For example, when the
collagenase assay was performed, MMP-8 was abundant in human wound fluid, but not
in the animal tissue. A possibility could be that MMP-8 is just not involved in
inflammation in rats as it is in humans. The data collected appeared to correlate with
research pertaining to humans, but it can not be certain. Until more research is
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conducted in human burn tissue, it is hard to determine whether this model can be
translated to humans.
An additional issue is whether heavy metal protoporphyrins can still
significantly modulate conversion when administered post-wounding. One of the
disadvantages to burn research is that it is impossible to know when an individual will
be burned. An interesting experiment would be to determine if heavy metal
protoporphyrins have any effect when administered to rats after the injury has occurred.
This could allow for a more practical method reducing burn wound conversion.
Although heavy metal protopophyrins modulate HO-1 expression and activity,
the approach used in this study does not definitively address whether HO-1 expression
itself, has a role in modulation of conversion. Future studies directly testing the ability
of HO-1 to modulate burn wound conversion still need to be performed. If HO-1 is
indeed serving a function, it will be necessary to determine the mechanism involved. It
has not been determined where exactly HO-1 acting. Is HO-1 mainly removing heme,
which can act as a potent oxidant? The key purpose of HO-1 may be to induce carbon
monoxide (CO) and biliverdin/bilirubin, which act as anti-oxidants and anti-apoptotic
molecules. Focusing on the true manner in which HO-1 expression occurs could give
extremely effective results. Lastly, it would be beneficial to determine how CO and
biliverdin/bilirubin directly or indirectly influence the injury. Their specific targets of
action would help to ascertain methods involved in decreasing the inflammatory
response in burn wounds in order to prevent conversion.
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